Valuation: CVRx, Inc.

Market Cap 144M 127M 117M 108M 204M 13.78B 208M 1.4B 547M 6.77B 541M 529M 23.4B P/E 2026 *
-2.77x
P/E 2027 * -2.87x
Enterprise Value 170M 149M 138M 127M 240M 16.22B 245M 1.65B 644M 7.97B 637M 623M 27.55B EV / Sales 2026 *
2.6x
EV / Sales 2027 * 2.79x
Free-Float
85.82%
Yield 2026 *
-
Yield 2027 * -
1 week-3.04%
Current month+5.64%
1 month+7.95%
3 months-24.11%
6 months-25.72%
Current year-23.52%
1 week 5.03
Extreme 5.03
5.93
1 month 4.76
Extreme 4.76
6.01
Current year 4.37
Extreme 4.3701
9.84
1 year 4.37
Extreme 4.3701
11.3
3 years 4.3
Extreme 4.2993
33.14
5 years 4.3
Extreme 4.2993
33.14
10 years 4.3
Extreme 4.2993
33.14
Manager TitleAgeSince
Chief Executive Officer 60 11/02/2024
Director of Finance/CFO 43 30/09/2020
Chief Operating Officer 57 10/08/2025
Director TitleAgeSince
Director/Board Member 61 30/09/2008
Director/Board Member 57 30/06/2020
Director/Board Member 52 30/06/2020
Date Insider Type Main position Quantity % Market Cap.
05-31Free

Director

19,902 0.0750%
05-31Free

Director

65,257 0.2459%
05-31Free

Director

19,902 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.04%-20.50%-65.65% 144M
+0.26%+0.12%+34.04%+0.31% 12.51B
0.00%-7.40%+56.04%+32.72% 5.87B
+1.20%+1.06%+12.23%+13.47% 5.87B
+5.30%+3.27% - - 4.29B
+1.14%+6.45%-29.76%+17.14% 4.26B
+1.11%-1.09%-24.13%-27.38% 3.83B
-3.33%-0.31%+7.77%+254.84% 1.94B
-1.29%-6.45%-8.58%-59.96% 1.89B
-0.66%+0.17%+54.20%-2.59% 1.56B
Average +0.37%-0.09%+9.03%+18.10% 4.22B
Weighted average by Cap. +0.76%-0.06%+18.15%+16.13%

Financials

2026 *2027 *
Net sales 65.28M 57.35M 53.18M 48.9M 92.4M 6.24B 94.34M 634M 248M 3.07B 245M 240M 10.6B 76.18M 66.92M 62.05M 57.06M 108M 7.28B 110M 740M 289M 3.58B 286M 280M 12.37B
Net income -52.82M -46.4M -43.03M -39.57M -74.76M -5.05B -76.33M -513M -201M -2.48B -198M -194M -8.58B -52.14M -45.8M -42.47M -39.06M -73.79M -4.99B -75.35M -506M -198M -2.45B -196M -192M -8.47B
Net Debt 25.51M 22.41M 20.78M 19.11M 36.11M 2.44B 36.87M 248M 96.92M 1.2B 95.79M 93.7M 4.14B 68.44M 60.12M 55.75M 51.27M 96.86M 6.54B 98.9M 665M 260M 3.21B 257M 251M 11.12B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
13/07/26 US$5.430 0.00% 225,194
10/07/26 US$5.430 +4.42% 140,461
09/07/26 US$5.200 -1.33% 203,370
08/07/26 US$5.270 -8.19% 223,998
07/07/26 US$5.740 +1.95% 307,627
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
5.430USD
Average target price
11.17USD
Spread / Average Target
+105.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock